DR. HEATHER BRODY NPI 1013301563

NPI Details

DR. Heather Brody is a hematology and oncology internal medicine in Florence, AL with 11 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Heather Brody NPI is 1013301563. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

180 COX CREEK PKWY S STE B
FLORENCE, AL
ZIP 35630-263
Phone: (256) 760-0422
Fax: (256) 284-6065

The NPI 1013301563 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg (HCPCS:Q5119)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Magnesium level (HCPCS:83735)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Nephelometry, test method using light (HCPCS:83883)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Folic acid level, serum (HCPCS:82746)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Unclassified drugs (HCPCS:J3490)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Phosphate level (HCPCS:84100)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Automated urinalysis test (HCPCS:81003)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection of drug or substance into vein (HCPCS:96374)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Protein measurement, serum (HCPCS:84165)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Urine volume measurement (HCPCS:81050)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Erythropoietin (protein) level (HCPCS:82668)
• Injection, morphine sulfate, up to 10 mg (HCPCS:J2270)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Translocation analysis (bcr/abl1) minor breakpoint (HCPCS:81207)
• Translocation analysis (bcr/abl1) major breakpoint (HCPCS:81206)
• Total protein level, urine (HCPCS:84156)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Administration of influenza virus vaccine (HCPCS:G0008)

The enumeration date for this NPI number is 3/23/2015 and was last updated on 4/22/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: